We are live on ! Find out more
CFB

Cullen/Frost Bankers Portfolio holdings

AUM $10.1B
1-Year Est. Return 29.18%
This Fund
S&P 500
This Quarter Est. Return
+0.61%
1 Year Est. Return
+29.18%
3 Year Est. Return
+91.06%
5 Year Est. Return
+115.39%
10 Year Est. Return
+478.9%
AUM
$4.95B
AUM Growth
-$29.6M
Cap. Flow
-$37.3M
Cap. Flow %
-0.75%
Top 10 Hldgs %
26.9%
Holding
1,264
New
51
Increased
187
Reduced
349
Closed
44

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$16.3M
2
LRCX icon
Lam Research
LRCX
+$8.6M
3
TMO icon
Thermo Fisher Scientific
TMO
+$5.48M
4
PLD icon
Prologis
PLD
+$4.96M
5
KKR icon
KKR & Co
KKR
+$3.48M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$13.2M
2
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$9.37M
3
VZ icon
Verizon
VZ
+$8.94M
4
FCX icon
Freeport-McMoran
FCX
+$6.85M
5
AAPL icon
Apple
AAPL
+$5.53M

Sector Composition

Rank Sector Weight
1 Technology 22.28%
2 Financials 13.64%
3 Consumer Discretionary 10.89%
4 Healthcare 10.87%
5 Communication Services 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRLB icon
1001
Protolabs
PRLB
$2.17B
$18K ﹤0.01%
273
SON icon
1002
Sonoco
SON
$5.74B
$18K ﹤0.01%
305
SPRO icon
1003
Spero Therapeutics
SPRO
$68.9M
$18K ﹤0.01%
1,000
TME icon
1004
Tencent Music
TME
$13.9B
$18K ﹤0.01%
2,439
UBSI icon
1005
United Bankshares
UBSI
$6.66B
$18K ﹤0.01%
505
VTLE
1006
DELISTED
Vital Energy
VTLE
$18K ﹤0.01%
225
WDFC icon
1007
WD-40
WDFC
$3.12B
$18K ﹤0.01%
77
CDK
1008
DELISTED
CDK Global, Inc.
CDK
$18K ﹤0.01%
416
EPAY
1009
DELISTED
Bottomline Technologies Inc
EPAY
$18K ﹤0.01%
459
INOV
1010
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$18K ﹤0.01%
456
-3,295
-88% -$125K
QADA
1011
DELISTED
QAD Inc.
QADA
$18K ﹤0.01%
210
AROC icon
1012
Archrock
AROC
$5.84B
$17K ﹤0.01%
2,014
CORP icon
1013
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
$17K ﹤0.01%
154
CUBE icon
1014
CubeSmart
CUBE
$9.28B
$17K ﹤0.01%
350
FCPT icon
1015
Four Corners Property Trust
FCPT
$2.74B
$17K ﹤0.01%
630
+182
+41% +$5.1K
OGE icon
1016
OGE Energy
OGE
$9.69B
$17K ﹤0.01%
518
DBEF icon
1017
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.44B
$16K ﹤0.01%
+425
New +$16.2K
HPP
1018
Hudson Pacific Properties
HPP
$777M
$16K ﹤0.01%
86
PARR icon
1019
Par Pacific Holdings
PARR
$3.9B
$16K ﹤0.01%
1,000
FUN icon
1020
Cedar Fair
FUN
$1.68B
$15K ﹤0.01%
333
XAR icon
1021
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.64B
$15K ﹤0.01%
124
XLB icon
1022
State Street Materials Select Sector SPDR ETF
XLB
$8.61B
$15K ﹤0.01%
380
-500
-57% -$20.8K
VIVO
1023
DELISTED
Meridian Bioscience Inc
VIVO
$15K ﹤0.01%
784
BOOM icon
1024
DMC Global
BOOM
$155M
$14K ﹤0.01%
376
CRT
1025
Cross Timbers Royalty Trust
CRT
$60.6M
$14K ﹤0.01%
1,002

Similar funds

Cullen/Frost Bankers's Q3 2021 Portfolio in Review

As of Q3 2021, Cullen/Frost Bankers held 1,264 positions worth $4.95B, down 0.59% from $4.98B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Cullen/Frost Bankers's Q3 2021 filing shows 51 new, 187 increased, 349 reduced and 44 closed positions. Its largest new stake was KKR & Co: 55,414 shares worth $3.37M. The largest sale was Vertex Pharmaceuticals, an estimated $13.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cullen/Frost Bankers's largest Q3 2021 buy was KKR & Co: 55,414 shares worth $3.37M.
  • Cullen/Frost Bankers added most to Chevron in Q3 2021, an estimated $16.3M increase.
  • Cullen/Frost Bankers's biggest Q3 2021 reduction was Vertex Pharmaceuticals, cutting an estimated $13.2M.
  • Cullen/Frost Bankers fully exited Maxim Integrated Products in Q3 2021, selling an estimated $1.24M.
  • Cullen/Frost Bankers's ten largest holdings make up 27% of its $4.95B portfolio in Q3 2021.
  • Cullen/Frost Bankers opened 51 new positions and closed 44 in Q3 2021.
  • Cullen/Frost Bankers's portfolio value fell 0.59% quarter-over-quarter to $4.95B.

Based on Cullen/Frost Bankers's 13F filing for Q3 2021, filed 4 Nov 2021.